I
ntracranial atherosclerosis (ICAS) is one of the most common causes of ischemic stroke and more prevalent in Asian populations. [1] [2] [3] However, how frequently ICAS is associated with emergent large vessel occlusion (LVO) eligible for endovascular treatment (EVT) remains unclear.
Mechanical thrombectomy using a stent retriever is a mainstay of modern EVT. [4] [5] [6] However, the stent retriever seems less effective for ICAS-related LVO (ICAS [+]-LVO) than purely embolic LVO (ICAS [−]-LVO). [7] [8] [9] Furthermore, the use of a stent retriever in ICAS (+)-LVO might cause more procedural complications. 1 Because of technical complexity and difficulty, opening ICAS (+)-LVO using recent pivotal mechanical thrombectomy modalities might be challenging. In particular, specific rescue modalities appropriate for underlying ICAS have been reported, such as balloon angioplasty, stenting, or intra-arterial infusion of glycoprotein IIb/IIIa inhibitors (GPIs) to achieve successful recanalization in ICAS (+)-LVO. [9] [10] [11] [12] [13] [14] [15] Fast recanalization is the most critical factor in favorable outcomes. 16 If procedural details and results may differ depending on the occlusion pathomechanism-ICAS (+) or (-)-LVO, the patient's outcomes might also be affected by the pathomechanism. Since EVT strategies for ICAS (+)-LVO have been actively pursued, the procedural outcomes have recently improved. [9] [10] [11] [12] [13] [14] [15] 17 Therefore, we inferred that clinical outcomes in patients with ICAS (+)-LVO might not be inferior to those in patients with ICAS (−)-LVO if comparable recanalization rates can be achieved. Accordingly, we evaluated the procedural outcomes and details to obtain a successful recanalization in patients with ICAS (+)-LVO and compared their clinical outcomes with those of patients with ICAS (−)-LVO.
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The patients were selected from a prospective registry in a tertiary stroke center. The intracranial internal carotid artery and M1 segment of middle cerebral artery were defined as intracranial large vessels.
Patients with an evident occlusion pathogenesis of arterial dissection were excluded. The institutional review board approved this study and waived the requirement of informed consent for study inclusion based on the retrospective design.
Patients eligible for intravenous tPA (tissue-type plasminogen activator) treatment were treated with 0.9 mg/kg of tPA. EVT was generally considered for patients who met the following criteria: (1) a computed tomographic angiography (CTA)-determined endovascularly accessible intracranial LVO associated with neurological symptoms; (2) within 8 hours from stroke onset; in the later study period, patients within 8 to 12 hours were also considered if they had an Alberta Stroke Program early CT score ≥7; and (3) baseline National Institutes of Health Stroke Scale score ≥4. We also generally performed EVT for patients with premorbid modified Rankin Scale score ≤3.
The data that support the findings of this study are available from the corresponding author on reasonable request.
Treatment Protocol
All EVTs were performed under local anesthesia. Based on the predetermined protocol, a stent retriever (Solitaire [ Rescue treatments were performed when occlusion was refractory even after several attempts using a stent retriever or the occlusion segment was recanalized with severe stenosis leading to significant flow limitation or the tendency to reocclude. Rescue EVT modalities included contact aspiration thrombectomy with Penumbra Reperfusion Catheter (Penumbra, Alameda, CA), intra-arterial urokinase infusion, mechanical clot disruption, percutaneous balloon angioplasty, intracranial stenting, and intra-arterial GPI infusion. Selection of the optimal rescue modality depended on the operator's judgement. For most patients with intracranial stenting, GPI was infused intra-arterially to solve or prevent acute in-stent thrombosis and the accompanying thromboembolism. Typically, 5 to 10 mg of abciximab or 0.5 to 2.0 mg of tirofiban was infused. To secure the stability of arterial patency achieved using balloon angioplasty, intracranial stenting or intra-arterial GPI infusion, serial delay angiograms were taken for at least 20 minutes after recanalization was achieved. When significant angiographic worsening in arterial patency and perfusion was not observed, the procedure was finished. If necessary, intravenous maintenance of GPI after the EVT was also considered. Oral administration of dual antiplatelets was started in patients on the day after the procedure if significant intracranial hemorrhage or other hemorrhagic complications were not present.
Successful recanalization was defined as achieving a modified thrombolysis cerebral ischemia grade 2b or 3 and not showing reocclusion on delay angiograms. Reocclusion was defined as the complete or incomplete occlusion events after sufficient recanalization. To become more stenotic, development of new filling defects and any flow impairment was regarded as incomplete occlusion. To identify the reocclusion events, angiographies were followed up for at least 20 minutes after recanalization.
Identification of the ICAS (+)-LVO
The ICAS (+)-LVO was identified based on the occlusion type. All occlusions were classified as either branching site or truncal type based on digital subtraction angiography (DSA). 9 An occlusion was classified as truncal type when all major branches and their bifurcation sites were clearly visible beyond the occlusion segment ( Figure I in the online-only Data Supplement). By contrast, if the occlusion met at least 1 of the following conditions, it was considered as a branching-site occlusion: (1) anterior communicating artery collateral flow that could not progress to the contralateral internal carotid artery because the contralateral internal carotid artery bifurcation site was involved, (2) direct visualization of Y-shaped filling defect involving a branching site, and (3) another branch could not be or only partially seen when the stent retriever was deployed to one branch across the occlusion site. Patients with truncal-type occlusion were considered to have an ICAS (+)-LVO. 9, 18 Identification of ICAS (±)-LVO by occlusion type could be free from vasospasm, arterial dissection, or remnant of embolus. Furthermore, occlusion type can be determined even in cases with persistent occlusion.
The occlusion type was assessed by 2 independent neurointerventionalists. The κ-value for the interrater reliability of DSA-determined occlusion type was 0.90. Discrepant cases were resolved by consensus. For cases in which the occlusion type could not be determined on DSA, mainly because of poor image quality or invalid distal confirmation, CTA was used to assess the occlusion type ( Figure I in the online-only Data Supplement). 18 The CTA-determined occlusion type had a κ-value of 0.97 for interrater reliability.
Clinical Outcomes
All clinical parameters, including functional outcome, death, and symptomatic intracranial hemorrhage (sICH), were collected from the prospective registry of patients with stroke.
Functional outcome and death were assessed based on the modified Rankin Scale score 3 months after stroke onset. A favorable outcome was defined as modified Rankin Scale score of 0 to 2. Functional outcome was primarily evaluated by stroke neurologists during the patient's routine clinic follow-up at 3 months±2 weeks. If a patient could not come to the clinic, a stroke neurologist or trained nurse interviewed the patient or their family via telephone to determine modified Rankin Scale score.
Intracerebral hemorrhage (ICH) was assessed on follow-up computed tomographic or magnetic resonance (gradient echo) images obtained 24±6 hours after EVT. The assessment of ICH was based on the consensus from stroke neurologists, neurointerventionalists, and neuroradiologists during the regular stroke conference. The determination of ICH was immediately entered into the prospective registry. ICH was defined as symptomatic if the patient's neurological symptoms worsened (National Institutes of Health Stroke Scale score increase ≥4) within 3 days. The National Institutes of Health Stroke Scale scores were fundamentally assessed by stroke neurologists or residents every 1 to 2 hours for the first 24 hours and then every 4 to 6 hours for 1 to 3 days after EVT, although the assessment interval was adjusted for neurological stability.
Statistical Analysis
Based on the determination of ICAS (+)-LVO, patients were assigned to the ICAS (+)-LVO group or the ICAS (−)-LVO group. Demographics, risk factors for atherosclerosis and stroke, procedural outcomes and details, and clinical outcomes, including functional outcome, death, and sICH, were compared between the ICAS (+)-LVO and (−)-LVO groups. Mann-Whitney U test, χ 2 test, and, Fisher exact test were used for comparison. A P value <0.05 was considered statistically significant for 95% CI. All statistical analyses were performed using R software (version 3.4.2; r-project.org).
Results

Participants
Among 489 patients who underwent EVT for an intracranial vessel occlusion (Figure) , 318 patients (mean age, 69.9±12.0 years; male patients, 50.0%) were included in the present study. Patients with distal artery occlusion (n=84), arterial dissection (n=2), and whose occlusion sites changed between CTA and DSA (n=1) were excluded. Regarding the location of occlusion, 204 patients (64.2%) had middle cerebral artery occlusion and 114 (35.8%) intracranial ICA occlusion.
Occlusion type was determined based on DSA in 293 patients (92.1%) and on CTA in 25 patients (7.9%). Of the included patients, 56 (17.6%) had an ICAS (+)-LVO. Smoking was more frequent in the ICAS (+)-LVO group, whereas atrial fibrillation was more frequent in the ICAS (−)-LVO group (Table 1) .
Procedural Outcomes and Details
Recanalization was successful in 277 patients (87.1%; Table 2 ). Successful recanalization rate in the ICAS (+)-LVO group (80.4%; n=45) was similar to the ICAS (−)-LVO group (88.5%; n=232; P=0.097). Successful recanalization was achieved using a stent retriever in 93.5% of patients (n=217) in the ICAS (−)-LVO group and only in 28.9% of patients (n=13) in the ICAS (+)-LVO group (P<0.001). The remaining patients in the ICAS (+)-LVO group (n=32; 71.1%) achieved recanalization using rescue treatments; 27 patients (84.3%) required specific rescue treatments appropriate for underlying ICAS to achieve successful recanalization, including balloon angioplasty, stenting, and intra-arterial GPI infusion. Notably, among those 27 patients, somewhat less than half of the patients (40.7%; 11 of 27) achieved a successful recanalization using only GPI, and 15 patients (55.6%; 15 of 27) eventually required rescue stenting. For them, Solitaire was used in 9 cases (60.0%) and Wingspan (Stryker, Kalamazoo, MI) in 6 (40.0%). For patients treated with GPI in the ICAS (+)-LVO group (n=24), abciximab was infused in 16 patients (66.7%; mean dose, 8.7±2.7 mg) and tirofiban in 8 patients (33.3%; mean dose, 1.3±0.7 mg).
Reocclusion events after initial recanalization using a stent retriever or contact aspiration thrombectomy were observed more frequently in the ICAS (+)-LVO group than in the ICAS (−)-LVO group (57.1% versus 3.4%; P<0.001). In the ICAS (+)-LVO group, 22 patients (68.8%) were treated with GPI for their initial reocclusion events among 32 with reocclusion events (Table I in (Table 2) . sICH was developed in 4.0% of patients treated with GPI, which was not significantly higher than in patients without GPI (5.1%; P=0.999).
Clinical Outcomes
Discussion
In this study, (1) This study reported clinical outcomes of patients with ICAS (+)-LVO in association with their procedural details. However, this study ultimately tries to provide help in setting up an optimal endovascular strategy in the ICAS (+)-LVO. For this, we will discuss about (1) the importance of recanalization in the ICAS (+)-LVO, (2) specific ways to get more successful recanalization in the ICAS (+)-LVO, and (3) the significance of an optimal endovascular strategy.
Until recently, the clinical outcomes of patients who underwent EVT for ICAS (+)-LVO have been reported in only a few studies. [19] [20] [21] [22] Furthermore, functional outcome results were inconsistent. Patients with ICAS (+)-LVO had 
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November 2018 more favorable outcomes than patients with ICAS (−)-LVO; however, they also showed less favorable outcomes or no significant difference in other studies. [19] [20] [21] Interestingly, the favorable functional outcome appeared closely proportionate to the recanalization success rate. In a previous study, more successful recanalization and favorable outcome rates were observed in patients with ICAS (+)-LVO, 19 however, vice versa in a different study. 20 In another study showing similar recanalization rates, functional outcomes were similar between patients with ICAS (+)-LVO and ICAS (−)-LVO. 21 The results observed in the present study also showed the same trend of relationship between recanalization success and favorable outcome rates. Consequently, the recanalization status might be a more relevant factor affecting patient's functional outcome than the occlusion pathogenesis. Therefore, identifying the underlying ICAS and setting an optimal strategy appropriate for ICAS might be a key to faster recanalization, leading to better clinical outcomes in patients with ICAS (+)-LVO.
Because of the introduction of highly effective endovascular modalities, such as stent retrievers, EVT outcomes have improved for patients with ICAS (−)-LVO. As a result, managing thrombectomy-refractory cases has currently become more important. One principal reason for the refractoriness is the occlusion pathogenesis, particularly the association with underlying ICAS. 7, 9, 15, 18 Until recently, recanalization of ICAS (+)-LVO has been a challenging issue in EVT. 17, 23, 24 Previous reports showed multimodal approaches, including balloon angioplasty, intracranial stenting, and intra-arterial GPI infusion, were required to open the ICAS (+)-LVO. [9] [10] [11] [12] [13] [14] [15] In the present study, although endovascular modalities were not regulated under a specific protocol, nonthrombectomy modalities were used in ≈70% of patients in the ICAS (+)-LVO group to achieve successful recanalization. Notably, balloon angioplasty, intracranial stenting, or intra-arterial GPI infusion were required in about 85% of cases as the rescue modality, which has been reported appropriate for ICAS thrombo-occlusion. [9] [10] [11] [12] [13] [14] [15] Conversely, the ICAS (−)-LVO group required nonstent retriever rescue modalities in <7% of cases. Contact aspiration thrombectomy or intra-arterial urokinase infusion was the most frequently used to rescue modalities in the ICAS (−)-LVO group, which has been reported appropriate for hard clots. 17, 25 Notably, GPI was fairly effective even without balloon angioplasty or intracranial stenting in the ICAS (+)-LVO group. In patients treated with ICAS-specific EVT modalities for the ICAS (+)-LVO, a successful recanalization was achieved in approximately half of the cases when using GPI alone. Furthermore, in about 70% of the patients who showed reocclusion events, GPI was first tried to resolve complete reocclusion or tendency for impending occlusion. The efficacy of intra-arterial GPI infusion for arterial reocclusion during EVT was well reported. 15, 26, 27 Endothelial irritability could play a key role in the reocclusion. Antiplatelet treatment with GPI could make the endothelium more stable, which could lead to reverse the in situ thrombotic occlusion. 9, 15, 17, 28 As an endovascular strategy for reocclusion, intra-arterial infusion could be a plausible firstchoice rescue modality based on the findings of this study. Even being confined to reocclusion or its tendency, about half of reocclusions were reopened, and their patency was well maintained. Then, one could consider additional stenting with/without balloon angioplasty if the GPI infusion does not work. By the additional stenting, about 30% of cases might get more successful recanalization after GPI treatment. On the contrary to the efficacy of GPI in the ICAS (+)-LVO group, it is not sure whether the procedural use of GPI is safe. 11, 29, 30 The procedural use of intra-arterial GPI did not significantly increase the development of sICH in our study population. However, there is still the common concern for hemorrhagic risk.
Acute intracranial stenting was also effective in the ICAS (−)-LVO group, although the number of patients was small. In fact, the intracranial stenting in the ICAS (−)-LVO group was not as effective as in the ICAS (+)-LVO group. Recanalization rate by the intracranial stenting was about 33% in the ICAS (−)-LVO group and about 88% in the ICAS (+)-LVO group (Table II in the online-only Data Supplement) . However, such a direct comparison should be cautiously interpreted because intracranial stenting was not tried in all patients without a successful recanalization.
Determining the appropriate time to introduce rescue modalities during EVT of ICAS (+)-LVO can be important. In our study, procedural time in the ICAS (+)-LVO group was longer than in the ICAS (−)-LVO group-a difference of ≈30 minutes. If the best endovascular modality can be determined for the patient with ICAS (+)-LVO, time to recanalization could be shortened, thus providing a better clinical outcome. To establish an optimal endovascular strategy, the most likely occlusion pathogenesis and the best endovascular modality for the occlusion pathomechanism should be considered. The better understanding of procedural process and details of EVT for ICAS (+)-LVO are needed when choosing the best endovascular modality for treating ICAS (+)-LVO.
This study had several strengths and limitations. First, because of the retrospective nature of the study, types and the timing of introduction of rescue modalities for ICAS (+)-LVO were not regulated under a specific protocol. As shown in the present and previous reports, recanalization is also a key factor affecting the clinical outcome in patients with ICAS (+)-LVO. Because the optimal endovascular strategy for ICAS (+)-LVO was not uniformly established, patients with ICAS (+)-LVO were treated using our best judgement, which resulted in a comparable recanalization rate. However, how their clinical outcome would be affected under the uniform endovascular protocol for ICAS (+)-LVO remains unclear, and a multicenter-based prospective study is necessary to validate these results. The findings from the present study can be helpful in daily EVT procedure. Furthermore, they can also be used as baseline data to design future prospective studies.
Second, although ICAS (+)-LVO was defined in the majority of our cases, it is not always possible. When a patient's 
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vascular imaging taken before an index stroke could not be assessed, one should depend on several types of surrogate markers for the underlying ICAS. In this study, we used the occlusion type-truncal type for ICAS (+)-LVO and branching site for ICAS (−)-LVO as previously reported to represent occlusion pathomechanism. 9 The occlusion type can be determined irrespective of recanalization status and even before starting endovascular procedure with CTA. 9, 18 Therefore, it is likely more objective in the present study than in the previous studies that compared outcomes between ICAS (+)-and (−)-LVO.
Third, this study was conducted in a single stroke center in an Asian country, where ICAS is more prevalent than in Western countries. However, overcoming refractoriness to modern mechanical thrombectomy techniques is an important issue. Furthermore, ICAS has been a main focus in Asian, Hispanic, and African populations in whom ICAS is one of the major causes of acute stroke. Therefore, evaluating procedural details and procedural and clinical outcomes of patients with ICAS (+)-LVO would be a matter of great importance in the era of EVT for acute stroke.
Conclusions
Procedural details for achieving successful recanalization in patients with ICAS (+)-LVO were significantly different from patients with ICAS (−)-LVO. Nevertheless, using a specific rescue treatment appropriate for underlying ICAS, patients with ICAS (+)-LVO had a similar recanalization rate to patients with ICAS (−)-LVO. With similar recanalization rates, clinical outcomes seemed to be comparable between patients with ICAS (+)-LVO and ICAS (−)-LVO.
